Cutler Group LP Clovis Oncology, Inc. Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$1.05 - $2.85 $9,926 - $26,943	-9,454 Reduced 39.35%	14,569 $17,000
Q2 2022 Aug 04, 2022	SELL	$0.63 - $2.96 $23,748 - $111,580	-37,696 Reduced 61.08%	24,023 $43,000
Q1 2022 Apr 14, 2022	BUY	$1.43 - $3.14 $74,387 - $163,339	52,019 Added 536.28%	61,719 $124,000
Q4 2020 Jan 21, 2021	SELL	$4.13 - $6.41 $24,780 - $38,460	-6,000 Reduced 38.22%	9,700 $46,000
Q3 2020 Oct 27, 2020	BUY	$4.82 - $7.72 $7,230 - $11,580	1,500 Added 10.56%	15,700 $91,000
Q2 2020 Jul 22, 2020	SELL	$5.69 - $9.69 $39,830 - $67,830	-7,000 Reduced 33.02%	14,200 $95,000
Q1 2020 May 07, 2020	SELL	$3.77 - $11.0 $13,949 - $40,700	-3,700 Reduced 14.86%	21,200 $134,000
Q4 2019 Feb 06, 2020	BUY	$3.0 - $16.43 $42,816 - $234,488	14,272 Added 134.29%	24,900 $259,000
Q4 2018 Feb 05, 2019	SELL	$11.63 - $32.67 $57,824 - $162,435	-4,972 Reduced 31.87%	10,628 $190,000
Q3 2018 Nov 07, 2018	SELL	$29.37 - $49.48 $79,299 - $133,596	-2,700 Reduced 14.75%	15,600 $458,000
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $340,686 - $505,440	-8,100 Reduced 30.68%	18,300 $832,000
Q1 2018 May 11, 2018	SELL	$50.12 - $67.72 $56,284 - $76,049	-1,123 Reduced 4.08%	26,400 $1.39 Million
Q4 2017 Jan 17, 2018	BUY	$57.69 - $84.58 $390,792 - $572,944	6,774 Added 32.65%	27,523 $1.87 Million
Q3 2017 Oct 17, 2017	BUY	$67.17 - $84.81 $1.39 Million - $1.76 Million	20,749	20,749 $1.71 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.